The management of Cohance Lifesciences Limited will be attending the Kotak Midcap Conference 2026 as part of investor relations activities.
The event is scheduled for 27 November 2026 in Mumbai.
The format includes both Group and One-on-One meetings with analysts and institutional investors.
The stated purpose is participation in an institutional investor conference for investor outreach and engagement.
The company explicitly states: "No unpublished price-sensitive information will be shared during this interaction."
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
No specific management participants or their designations were disclosed in this filing.
The document does not mention any presentation, earnings deck, transcript, or recording being made available.
Additional Notes Section
The document includes a note that the schedule is subject to change due to exigencies on the part of analysts, institutional investors, or the company.
No financial data, guidance references, or presentation summaries were included in this announcement.
The letter was digitally signed by Sisir K. Mishra, Company Secretary & Compliance Officer, on November 20, 2026.